Displaying archives for January 2019 - ALCMI - Addario Lung Cancer Medical Institute:

Remote Participation Enables Patients with ALK-Positive Lung Cancer from Across the Country to Participate in New Study of Treatment Resistance

Posted by Bradley Newton on January 24th, 2019 |

The Addario Lung Cancer Medical Institute (ALCMI), a patient-founded not-for-profit global research consortium, and researchers from the Dana-Farber Cancer Institute are launching a novel nationwide […]